NON-METASTATIC PROSTATE CANCER
Clinical trials for NON-METASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-METASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for NON-METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo shows promise against tough prostate cancer
Disease control OngoingThis early-stage study tests two oral drugs, darolutamide and abemaciclib, plus standard hormone therapy in men with high-risk prostate cancer that has spread or may come back. The first part finds the safest dose; the second checks if the combo can shrink tumors before surgery. …
Matched conditions: NON-METASTATIC PROSTATE CANCER
Phase: PHASE1 • Sponsor: Praful Ravi, MB BCHir, MRCP • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Which prostate cancer drug is kinder to your brain?
Knowledge-focused OngoingThis study looks at how two different prostate cancer medications, darolutamide and enzalutamide, affect thinking skills like memory and attention. About 111 men with advanced prostate cancer will take one of the two drugs and complete computer-based brain tests over time. The go…
Matched conditions: NON-METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC